Pay in 4 interest-free payments of $5.37 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
ClinicalTrials.gov Identifier: NCT04370288
Indeed, immunoblotting using a commercial antibody that specifically recognizes phosphorylated AKT substrates (referred to as p-AKT-sub) indicated that UFL1 was phosphorylated in MDA-MB-231 cells, and this phosphorylation was enhanced by insulin, which activates AKT1 (Fig
This timeframe has influenced anecdotal discussions around cycle length
The buyer assumes full responsibility for safe handling, storage, and lawful use in accordance with all applicable regulations
Product specifications CAS Registry Number 885340-08-9344 Reported purity 98.5% Form Lyophilized laboratory research material Intended use Qualified in vitro laboratory research only
US$ 27.11
US$ 21.21
US$ 23.82
